Lanugo Hair Loss as a Marker for Peri-ocular Malignancy
NCT ID: NCT03382704
Last Updated: 2017-12-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2018-04-30
2018-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study looks at whether the loss of fine hairs (lanugo hairs) on the skin are a good indicator of whether a lump is a skin cancer or not.
The investigators are recruiting patients who have lid lumps who haven't had a biopsy before, who would be having a biopsy as part of their treatment, and seeing whether those who have loss of the fine skin hairs are the same as those who have skin cancer confirmed on their biopsy.
The study doesn't involve any extra examinations or treatments for participants. The investigators look at the patients before the biopsy as part of their usual care, and take a note of whether or not they have lost the fine hairs at this stage.
The main benefit of participating is that the medical community has better evidence about which lid lumps are likely to represent skin cancer, helping future diagnosis.
There are no additional risks to participating. The risks of biopsy are unchanged whether patients participate in the study or not.
The study is run from the Princess Alexandra Eye Pavilion in Edinburgh, in conjunction with Moorfields Eye Hospital, London
The investigators aim to start the study in Spring 2018, and will most likely recruit for 6 months depending on the number of participants recruited.
There is no additional funding from any source at present - the work will be undertaken by doctors in their research time.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients undergoing biopsy
Patients undergoing biopsy (incisional or excisional) of peri-ocular lesions. Pre-operative examination for presence or absence of lanugo hairs
Examination for presence or absence of lanugo hairs
Pre-operative examination for presence or absence of lanugo hairs
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Examination for presence or absence of lanugo hairs
Pre-operative examination for presence or absence of lanugo hairs
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Moorfields Eye Hospital NHS Foundation Trust
OTHER
Robert Peden
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Robert Peden
Speciality Registrar
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert G Peden, MA; MBBS
Role: PRINCIPAL_INVESTIGATOR
NHS Lothian
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Princess Alexandra Eye Pavilion
Edinburgh, Midlothian, United Kingdom
Moorfields Eye Hospital
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Robert G Peden, MA; MBBS
Role: primary
Mark R Wright
Role: backup
Hannah Timlin
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
229755
Identifier Type: -
Identifier Source: org_study_id